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Abstrak 
 Stroke merupakan suatu penyakit dengan morbiditas dan mortalitas yang tinggi, baik 
di Indonesia maupun negara-negara lain. Hiperhomosisteinemia merupakan salah satu faktor 
risiko penyakit pembuluh darah, antara lain stroke iskemik. Penelitian ini bertujuan untuk 
mengevaluasi apakah hiperhomosisteinemia merupakan suatu faktor risiko independen pada 
kejadian stroke iskemik di Rumah Sakit Immnuel Bandung. 
Pada penelitian yang bersifat observasional deskriptif ini, dicari data berbagai faktor 
risiko  penderita stroke iskemik akuta (SIA). Data diperoleh dari rekam medik RS Immanuel 
periode Juli 2003 sampai  dengan Agustus 2004. Kemudian data dianalisis secara statistik 
untuk mencari nilai rerata, standar deviasi, dan proporsi dari setiap faktor risiko yang 
menimbulkan SIA pada selang kepercayaan 95%. 
Dari 37 orang penderita SIA ( 23 pria, 14 wanita, usia rata-rata 58,35 tahun ) yang 
memenuhi kriteria penelitian, didapatkan hasil kadar plasma homosistein total (tHcy) 
12,08µmol/L , SD 6,57µmol/L , proporsi 43,2% (95%CI:27,2-59,2). Sedangkan kadar plasma 
kolesterol total, trigliserida, LDL kolesterol, HDL kolesterol berturut turut adalah 188 mg/dl , 
SD 33,3 mg/dl , proporsi 35,1% (95%CI:16,1-36,9) ; 141 mg/dl , SD 45,1 mg/dl , proporsi 
24,1% (95%CI:10,2-26,1) ; 120,5 mg/dl , SD 30,1 mg/dl , proporsi 37,8% (95%CI:18,2-39,5) ; 
43,7 mg/dl , SD 10,4 mg/dl , proporsi 27,1% (95%CI:11,8-40,8). Faktor risiko lain seperti 
hipertensi, diabetes mellitus, dan merokok  merupakan kriteria eksklusi. Dari 37 orang sehat 
yang menjadi kontrol (serupa dalam usia dan gender) didapatkan hasil kadar tHcy 8.48µmol/L, 
SD 2.48µmol/L, proporsi 10.8% (95%CI : 2.78-13.2), p<0.005. Odds rasio 
hiperhomosisteinemia sebagai faktor risiko SIA adalah 6.28.  
 Dapat disimpulkan bahwa hiperhomosisteinemia nampaknya merupakan suatu faktor 
risiko independen terhadap penderita stroke iskemik akuta di Rumah Sakit Immanuel Bandung. 
 
Kata kunci  :  hiperhomosisteinemia, stroke iskemik,  faktor risiko independen 
 
 
 
Introduction 
Homocysteine, a normal 
breakdown product of the essential 
amino acid methionine, is believed 
to exert several toxic effects. 
Increased homocysteine levels may 
also be a risk factor for the develop-
ment of many other conditions, 
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including stroke, thromboembolism 
(blood clots that can dislodge and 
cause stroke, heart atttack, and 
other complications), osteoporosis, 
inflammatory bowel disease 
(Chron’s disease and ulcerative 
colitis), Alzheimer’s disease, death 
from diabetes, miscarriage, and 
other complications of pregnancy 
and hypothyroidism (Boushey, 
1995).   Scientists have yet to prove 
that elevated homocysteine levels 
cause any of these diseases. 
However, most doctors believe that 
high homocysteine increases the 
risk of at least heart disease. 
Fortunately, homocysteine levels 
can easily be reduced with safe and 
inexpensive B vitamin supplemen-
tation. 
Hyperhomocysteinemia can 
cause adverse vascular effects, 
involving oxidative damage to vas-
cular endothelial cells and increas-
ing proliferation of vascular smooth 
muscle cells after metabolism of 
homocysteine to homocysteine 
thiolactone. Oxidative modification 
of low-density lipoprotein (LDL) 
promotes the formation of foam 
cells, which in turn yields another 
source of reactive oxygen species 
(ROS). Endothelial dysfunction, 
prolifera-tion of vascular smooth 
muscle cells, lipid peroxidation, 
and oxidation of LDL caused by 
ROS can induce atherothrombosis 
(Gouaille, 1999). The reference for 
normal tHcy level in human adults 
is variable, but in the range of 5 to 
15 µmol/L. In this study, we take a 
plasma tHcy level exceeding 11.35 
µmol/L to characterize hyper-
homocysteinemia (Widjajakusuma, 
2001).   
 Stroke is the third leading 
cause of death and a significant 
cause of disability in the United 
States. Of the roughly 600,000 new 
and recurrent cases of stroke each 
year, 160,000 are fatal. Currently, 
there are 4 million stroke survivors, 
many of whom have significant 
disabilities, and more than $50 
billion is spent on stroke care each 
year (Ingall, 2001). The main focus 
of primary stroke prevention is 
modification of risk factors for 
stroke. Old age, male sex, race (eg, 
African American), and heredity 
are clearly documented stroke risk 
factors and are nonmodifiable. The 
modifiable risk factors that have 
been identified include hyper-
tension, diabetes mellitus, smoking, 
and various cardiac conditions 
(table 1).  
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Table 1.  Stroke Risk Factors (Ingall,2001) 
 
Nonmodifiable                                             Cardiac 
Older age                                                       Atrial fibrillation 
Male sex                                                        Coronary artery disease 
Race                                                              Congestive heart failure 
Genetic factors                                               Left ventricular dysfunction with mural thrombus 
Modifiable                                                    Mitral stenosis 
Hypertension                                                  Left ventricular hypertrophy 
Cigarette smoking                                          Patent foramen ovale 
Carotid artery stenosis                                    Atrial septal aneurysm 
Physical inactivity                                           Mitral annular calcification 
Diabetes mellitus                                            Mitral valve strands 
Hyperlipidemia                                               Aortic arch atheroma 
Transient ischemic attack                               Aortic stenosis 
                                                                      Mitral valve prolaps
 
Regular exercise has been 
shown to reduce premature mor-
tality from cardiovascular diseases. 
Until recently, however, the effect 
of physical activity on risk of stroke 
was unclear. Data from the 
Northern Manhattan Stroke Study  
showed that leisure-time physical 
activity significantly reduced the 
risk of stroke among men and 
women; young and old; and 
whites, blacks, and Hispanics 
(overall adjusted odds ratio [OR], 
0.37; 95% CI, 0.25 to 0.55). A dose-
response relationship was seen 
with both intensity of physical 
activity (light-moderate activity 
OR, 0.39; heavy activity OR, 0.23) 
and duration of activity (<2 hr/wk 
OR, 0.42; 2 to 5 hr/wk OR, 0.31). 
The Center for Disease Control and 
Prevention recommends that all 
persons engage in at least 30 
minutes of moderately intense 
physical activity on most, and 
preferably all, days of the week 
(Ingall, 2002). 
 Diabetes mellitus is a well-
recognized independent risk factor 
for stroke. After adjustment for the 
confounding effects of other risk 
factors, the relative risk of stroke 
associated with diabetes has been 
estimated to be 1.5 to 3. Whether 
hyperlipidemia is a risk factor for 
stroke is still uncertain. Many 
studies have shown that it is a 
modifiable risk factor for coronary 
heart disease, but epidemiologic 
evaluation has not established a 
conclusive link between hyper-
lipidemia and stroke. Although a 
direct correlation between hyperl-
ipidemia and clinical outcome of 
stroke has yet to be clearly 
established, recent evidence has 
shown that lowering elevated lipid 
levels with statin medications is 
associated with a reduction in the 
occurrence of first stroke, especially 
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in patients with coexisting coronary 
heart disease.  
The purpose of this study is 
to evaluate hyperhomocysteinemia 
as an independent risk factor for 
acute ischemic stroke in Immanuel 
Hospital patients. 
 
 
Material and Method 
This research was a 
descriptive-observational retrospec-
tive study and performed by 
identification total plasma homo-
cysteine (tHcy) levels and other risk 
factors such as lipid profile among 
acute ischemic stroke (AIS) patients 
and healthy-control populations 
based on the research criteria. The 
data were collected from Immanuel 
Hospital’s medical records  from 
July, 2003 to August, 2004. 
Inclusion criteria :  
• Ischemic stroke patients, diag-
nosed by clinical and laboratory 
examination and brain CT-scan 
• Within 2 weeks after the first 
clinical manifestations 
• 40  to 80  years old male or fe-
male 
Exclusion criteria : 
• Malnutrition, Alcoholics, Smo-
kers,  
• Renal disease, Diabetes melli-
tus, Hypertension, Neoplasia, 
Hypothyroidism 
• Ongoing therapeutic drugs 
such as cholestyramine, fibrate, 
metformin, methotrexate, anti-
convulsant, penicillinamine, 
acetylcysteine, and theophylline 
 
 
Results 
Based on the research crite-
ria, there were 37 acute ischemic 
stroke (AIS) patients and 37 
healthy-control subjects matched in 
age and gender ( 23 male and 14 
female, with the mean age being 
58.35 years old). The mean value 
and standard deviation from the 
baseline characteristics of the AIS 
patients and control group can be 
seen in table 2.  
In tables 3 and 4, we can see 
the proportion of each risk factor 
(homocysteine and the lipid profile) 
for becoming an acute ischemic 
stroke. We have already excluded 
the other risk factors (diabetes 
mellitus, hypertension, and smok-
ing). Based on table 3, we calculat-
ed the odds ratio of hyperhomo-
cysteinemia and its value was 6.28. 
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Table 2.  Baseline characteristics of the  subjects ( AIS and Control ) 
 
                                                               AIS Group      Control Group 
                                                                 ( n=37 )           ( n = 37 )                p 
 
1. Gender : - male                                    23                        23 
                   - female                                14                        14 
2. Age (years)                                        58.35 (7.18)        58.35 (7.18) 
3. Biochemical markers (plasma): 
      -Total homocysteine (µmol/L)        12.08  (6.57)       8.48 (2.48)        <0.005 
-Total cholesterol (mg/dl)                  188  (33.3)                   
-LDL cholesterol (mg/dl)                120.4  (30.1)                
-HDL cholesterol (mg/dl)                 43.7  (10.4)                 
-Triglyseride (mg/dl)                        141  (45.1)                   
-Glucose fasting (mg/dl)                   96.6  (20.5)                 
-2 hr post prandial (mg/dl)    110.4  (29.4)               
-Creatinine (mg/dl)                           0.97  (0.24)                 
-Natrium (meq/L)                           135.4  (7.30)               
-Potassium (meq/L)                          4.32  (0.97)                 
 
     AIS : acute ischemic stroke;  p : significancy (Student t-Test, 95%CI) 
 
 
 
Table 3.  The distribution of hyperhomocysteinemia in AIS and Control 
 
                                                       AIS       Control                   Proportion 
                                                       ( n )         ( n )                   ( % ; 95%CI ) 
                                                                           
                                     ( + )            16            4 
    Hyperhomocysteinemia                                           AIS : 43.2% (95%CI:27.2-59.2) 
     ( > 11.35µmol/L)     ( – )            21           33 
                                                                                 Control : 10.8% (95%CI:2.7-13.2)   
                                                       37            37      
 
           AIS : acute ischemic stroke 
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Table 4.  The distribution of lipid profile in AIS patients 
   
                                                                  AIS                         Proportion 
                                                                  ( n )                       ( % ; 95%CI ) 
                                                                           
                                                    ( + )            13    
       Hyper-Total Cholesterolemia                                               35.1% (95%CI:16.6-36.9) 
           ( > 200 mg/dl )                 ( – )             24                     
                                                              
                                                                       37 
  
( + )           9  
       Hyper-Triglyceridemia        24.1% (95%CI:10.2-26.1) 
 ( > 150 mg/dl )              ( – )    28   
 
                                                                        37 
 
( + )        14  
       Hyper-LDL cholesterolemia                     37.8% (95%CI:18.2-39.5) 
 ( > 130 mg/dl )              ( – )  23   
 
                                                                      37 
 
( + )        10  
       Hypo-HDL cholesterolemia                     27.1% (95%CI:11.8-40.7) 
 ( < 40 mg/dl )              ( – )  27   
 
                                                                      37 
           
    AIS : acute ischemic stroke   ; CI : confidence interval 
 
 
 
Discussion 
The mean concentration of 
total plasma homocysteine (tHcy) 
in acute ischemic stroke patients in 
Immanuel Hospital is 12.08 
µmol/L, and this value is signi-
ficantly different from the one in 
healthy-control subjects ( 8.48 
µmol/L ), with p < 0.005 (Santosa, 
2005). This condition is the same as 
the other researches, that there is an 
increase of total plasma homo-
cysteine (tHcy) levels in acute 
ischemic stroke patients. However, 
the tHcy level in acute ischemic 
stroke patients in Immanuel Hos-
pital (12.08 µmol/L) was different 
from the others (Eikelboom : 12.7 
µmol/L ; Tan : 13.4 µmol/L ; 
Adunsky : 13.8 µmol/L ; Tanne : 
17.4 µmol/L ; Pratama : 17.72 
µmol/L). The differences might be 
caused by nonmodifiable and mo-
difiable predisposition factors such 
as age, race, ethnicity, genetic, daily 
diet, smoking, blood lipid levels, 
and the preparation of the blood 
samples. Anyhow, these various 
 29
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tHcy levels in AIS patients are still 
significant compared to the normal 
populations. (Eikelboom : 10.5 
µmol/L, p=0.004 ; Tan : 10.5 
µmol/L, p<0.001 ; Adunsky : 9.8 
µmol/L, p<0.001 ; Pratama : 15.11 
µmol/L, p=0.021 ; Santosa : 8.48 
µmol/L, p<0.005 ).    
In this study, all subjects in 
acute ischemic stroke (AIS) group 
has normal value limits for the 
other risk factors such as blood 
total cholesterol, LDL cholesterol, 
HDL cholesterol, triglycerides, and 
blood glucose. Together with 
normal blood pressure levels and 
non-smoking habit of the subjects, 
these conditions indicate that there 
is no influence by the other risk 
factors for becoming an acute 
ischemic stroke in our subjects. 
Furthermore, hyperhomocysteine-
mia is indicated as a risk factor for 
ischemic stroke (odds ratio 6.28), 
and this feature is similar to the 
others. Tanne reports that hyper-
homocysteinemia has 3.3 fold 
increase to become ischemic stroke, 
while in Pratama study it is 3.22 
times greater and Tan report that 
the risk factor for stroke is 2.53 
times greater in hyperhomo-
cysteinemia patients.  These 
relative risk differences might be 
due to the differences in age, race, 
ethnic, gender, and genetic factors.   
The prevalence of hyper-
homocysteinemia in acute ischemic 
stroke patients in this study (43.2%) 
is different from the others 
(Lumenta : 33.3% ; Tan : 53% ; 
Pratama : 72.5%).  The differences 
might be caused by the various 
normal value limits of the plasma 
tHcy level (Tan : 12.0 µmol/L  ;  
Pratama : 15.0 µmol/L ;  
Widjajakusuma : 11.35 µmol/L). 
Considering with the prevalence of 
lipid profiles in this study, we can 
seen that hyperhomocysteinemia 
had a greater prevalence than lipid 
profiles for becoming a risk factor 
for AIS. Unfortunately, we do not 
have data about lipid profiles of the 
control subjects and the other 
modifiable and non-modifiable risk 
factors for ischemic stroke.  
 
 
Conclusions 
1. There is an indication that 
hyperhomocysteinemia is an in-
dependent risk factor for vascu-
lar diseases such as acute ische-
mic stroke. 
2. The concentration of total plas-
ma homocysteine (tHcy) in 
acute ischemic stroke patients 
in Immanuel Hospital is greater 
than that in healthy popula-
tions. 
3. The prevalence of hyperhomo-
cysteinemia in acute ischemic 
stroke patients in Immanuel 
Hospital is greater than that in 
healthy populations. 
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